Cargando…

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

OBJECTIVE: The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeshige‐Amano, Haruka, Saiki, Shinji, Fujimaki, Motoki, Ueno, Shin‐Ichi, Li, Yuanzhe, Hatano, Taku, Ishikawa, Kei‐Ichi, Oji, Yutaka, Mori, Akio, Okuzumi, Ayami, Tsunemi, Taiji, Daida, Kensuke, Ishiguro, Yuta, Imamichi, Yoko, Nanmo, Hisayoshi, Nojiri, Shuko, Funayama, Manabu, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496239/ https://www.ncbi.nlm.nih.gov/pubmed/32357260 http://dx.doi.org/10.1002/mds.28068

Ejemplares similares

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
por: Ueno, Shin‐Ichi, et al.
Publicado: (2020)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Metabolomics‐based identification of metabolic alterations in PARK2
por: Okuzumi, Ayami, et al.
Publicado: (2019)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
por: Yamaguchi, Akihiro, et al.
Publicado: (2020)

Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
por: Uehara, Yuya, et al.
Publicado: (2021)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD
por: Miyamoto, Kengo, et al.
Publicado: (2022)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

White matter and nigral alterations in multiple system atrophy-parkinsonian type
por: Ogawa, Takashi, et al.
Publicado: (2021)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

Radiation-induced Brain Calcification Leads to L-dopa-resistant Parkinsonism and Cerebellar Ataxia
por: Shimada, Tomoyo, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

p150(glued)-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway
por: Ishikawa, Kei-Ichi, et al.
Publicado: (2014)

A complex form of hereditary spastic paraplegia harboring a novel variant, p.W1515*, in the SPG11 gene
por: Daida, Kensuke, et al.
Publicado: (2022)

Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis
por: Nakazato, Tomoko, et al.
Publicado: (2022)

Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment
por: Okuzumi, Ayami, et al.
Publicado: (2018)

Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study
por: Saito, Tomoyuki, et al.
Publicado: (2020)

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
por: Daida, Kensuke, et al.
Publicado: (2020)

Differences in Clinical Features in Patients with Acute Coronary Syndrome and Stroke: Japanese Multicenter Registry Results
por: Naito, Ryo, et al.
Publicado: (2018)

Molecular genetics of Parkinson’s disease: Contributions and global trends
por: Funayama, Manabu, et al.
Publicado: (2022)

Metabolomic analysis data of MPP(+)-exposed SH-SY5Y cells using CE-TOFMS
por: Amo, Taku, et al.
Publicado: (2020)

Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
por: Takeshige, Haruka, et al.
Publicado: (2018)

Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma
por: Nishioka, Kenya, et al.
Publicado: (2017)

Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson’s disease: a case report
por: Igami, Eriko, et al.
Publicado: (2022)

Oxidative stress‐induced phosphorylation of JIP4 regulates lysosomal positioning in coordination with TRPML1 and ALG2
por: Sasazawa, Yukiko, et al.
Publicado: (2022)

Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission
por: Imamura, Yukio, et al.
Publicado: (2022)

CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification
por: Daida, Kensuke, et al.
Publicado: (2017)

Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project
por: Ohmura, Hirotoshi, et al.
Publicado: (2019)

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan
por: Oyama, Genko, et al.
Publicado: (2023)

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)

Predictors of Small Bowel Transit Time for Capsule Endoscopy in Children with Inflammatory Bowel Disease
por: Oka, Itsuhiro, et al.
Publicado: (2023)

Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits
por: Amano, Shinichi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uqig3ifkpn3rds8v5kg4l5v2vu